Alternative Chemotherapy for Concurrent Chemoradiation in Hypopharynx Cancer

Primary Alternative: Carboplatin-Based Regimens

The American Society of Clinical Oncology recommends carboplatin at AUC 5-6 administered every 3 weeks concurrently with radiotherapy as the strongest evidence-based alternative to cisplatin for hypopharyngeal cancer patients with cisplatin contraindications 1, 2, 3, 4
The ASCO larynx preservation guideline explicitly recommends carboplatin for patients with cisplatin contraindications 5

The Chinese Society of Clinical Oncology and American Society of Clinical Oncology guidelines recommend nedaplatin at 100 mg/m² every 3 weeks as an alternative platinum agent for concurrent chemoradiation when cisplatin is contraindicated 1, 2, 3, 4
Oxaliplatin at 70 mg/m² weekly represents another guideline-endorsed option with intermediate-quality evidence for hypopharyngeal cancer patients with cisplatin contraindications 1, 2, 3, 4

If all platinum-based chemotherapy is contraindicated, fluoropyrimidines with concurrent radiotherapy may be offered, though this carries low-quality evidence and weak recommendation strength 1, 2, 3, 4

Target AUC 5-6 every 3 weeks for at least 3 cycles to achieve adequate cumulative exposure during the 6-7 week radiotherapy course for carboplatin regimens 1, 6

Hypopharyngeal cancer has a poor prognosis with 5-year overall survival of only 15-22% despite aggressive treatment, highlighting the importance of achieving adequate locoregional control through optimal chemoradiation 7

Do not use cetuximab as a substitute for platinum agents in the definitive concurrent setting for hypopharyngeal cancer, as it demonstrates inferior outcomes compared to platinum-based regimens 8
Do not use weekly carboplatin in the postoperative setting, as this has been specifically contraindicated by ASCO guidelines 8
Avoid sequential induction chemotherapy followed by concurrent chemoradiation unless specifically pursuing organ preservation in patients who would otherwise require total laryngectomy 5, 7